Stereotaxis, INC 10-Q quarterly reports

Stereotaxis reported a decrease in Q2 2026 revenue to $7.7 million, primarily driven by lower system sales, while net loss widened, despite progress in product development and the recent acquisition of Robocath.

Stereotaxis reports a 19% revenue decrease in Q3 2025, but a 15% increase year-to-date, driven by disposables, alongside key regulatory approvals and a $7.8 million equity raise.

Stereotaxis, Inc. reported a significant increase in second-quarter revenue driven by system sales and disposable products, alongside progress in regulatory approvals for its robotic navigation systems and catheters, despite ongoing net losses and macroeconomic headwinds.

Stereotaxis saw a revenue increase in Q1 2025, but continues to operate at a loss, with potential tariff implications looming.

Stereotaxis' Q3 2024 results show a revenue increase but also a net loss, influenced by the acquisition of Access Point Technologies EP, Inc. and ongoing market challenges.

Stereotaxis' Q2 2024 results show a decrease in revenue compared to the same period last year, alongside the completion of the acquisition of Access Point Technologies.

Stereotaxis, Inc. announced its first quarter 2024 financial results, showing a 5% increase in revenue compared to the same period last year, driven by higher system sales.